次世代定序(NGS) 样品製备市场规模、份额和成长分析（按产品/服务、工作流程、样品类型、方法、应用、最终用户和地区划分）－2026-2033 年产业预测

预计次世代定序(NGS) 样品製备市场在 2024 年的价值为 21 亿美元，从 2025 年的 24 亿美元成长到 2033 年的 70.2 亿美元，在预测期（2026-2033 年）内的复合年增长率为 14.32%。

受高通量定序技术广泛应用的推动，全球次世代定序(NGS) 样本製备市场正经历显着成长。这个关键流程涉及製备 DNA 或 RNA 样本，以确保定序结果的准确性和品质。 NGS 样本製备能够提供关于遗传物质和生物功能的关键讯息，因此备受青睐。奈米技术的创新，例如奈米磁珠、奈米流体和微流体，正在重塑样本製备方法。这些最尖端科技透过实现更快、更精确的处理来优化效率，最终降低成本并缩短週转时间。因此，NGS 样本製备正变得越来越容易被更广泛的研究人员和临床医生所接受，从而推动市场扩张。

NGS样品製备市场驱动因素

次世代定序(NGS) 样本製备市场的发展动力源自于其在基因组研究诸多应用中的关键作用，包括基因表现分析、突变检测、生物标记发现和总体基因体学。基因组学技术的进步推动了对高效能、高通量样品製备技术（特别是针对次世代定序製备技术）的需求。这种需求的激增凸显了开发创新方法以提高样品製备速度和可靠性的重要性，从而支持更广泛的基因组研究目标，并帮助科学家揭示遗传物质的重要资讯。这些技术的持续发展将进一步促进市场成长和研究能力的提升。

次世代定序(NGS) 样品製备市场的限制因素

次世代定序产生的大量资料为NGS样本製备市场带来了巨大挑战。如此庞大的资料量需要先进的生物资讯学工具和大规模储存解决方案，这使得基因组资料集的分析和管理变得更加复杂。应对这种复杂性需要经验丰富的生物资讯专家、强大的基础设施和安全的储存系统。这些要求构成了障碍，可能会阻碍NGS样本製备技术的广泛高效应用，从而限制其在各种基因组研究和临床应用中的可用性和有效性。

次世代定序（NGS）样品製备市场趋势

推动全球次世代定序(NGS) 样品製备市场发展的一大趋势是加速向自动化和高通量解决方案转型。这一趋势的驱动力源于对高效且扩充性的样品处理方法的需求，以应对 NGS 工作流程中日益增长的样品量。自动化样品製备系统具有许多优势，包括减少人工干预、提高重复性、提升准确性和增加样品通量。先进的机器人技术和创新的液体处理技术的集成，简化了包括 DNA/RNA 提取、样品製备和靶向序列捕获在内的各种关键流程，最终提高了基因组分析的效率和可靠性。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析及其影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 客户和购买标准分析
• PESTEL 分析
• 总体经济指标
• 市场吸引力指数
• 定价分析

全球次世代定序(NGS) 样品製备市场规模（按产品/服务划分）及复合年增长率 (2026-2033)

• 工作站/设备
• 试剂和耗材
• 服务

全球次世代定序(NGS) 样品製备市场规模（按工作流程和复合年增长率划分）（2026-2033 年）

• DNA片段化与样品製备
• 目标富集
• 品管

全球次世代定序(NGS) 样品製备市场规模（按样品类型划分）及复合年增长率 (2026-2033)

• DNA
• RNA

全球次世代定序(NGS) 样品製备市场规模（按方法和复合年增长率划分）（2026-2033 年）

• 手动样品製备
• 微流体样品製备
• 基于自动化液体处理的样品製备

全球次世代定序(NGS) 样品製备市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 疾病诊断
  • 癌症诊断
  • 生殖健康检查
  • 感染疾病诊断
  • 其他的
• 药物发现
• 农业和畜牧业调查
• 其他的

全球次世代定序(NGS) 样品製备市场规模（依最终用户划分）及复合年增长率 (2026-2033)

• 医院和诊所
• 学术机构与研究中心
• 製药和生物技术公司
• 其他的

全球次世代定序(NGS) 样品製备市场规模及复合年增长率 (2026-2033)

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Revvity Inc.
• Agilent Technologies, Inc.
• Danaher
• Becton, Dickinson and Company
• Qiagen
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• Eurofins Scientific
• BGI Group
• 10x Genomics
• Sysmex Corporation
• Psomagen
• Zymo Research Corporation
• Takara Holdings Inc
• Nanjing Novogene Bio Technology Co., Ltd.
• New England Biolabs

结论与建议

NGS Sample Preparation Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.4 Billion in 2025 to USD 7.02 Billion by 2033, growing at a CAGR of 14.32% during the forecast period (2026-2033).

The global NGS (Next-Generation Sequencing) sample preparation market is experiencing substantial growth, driven by the increasing adoption of high-throughput sequencing technologies. This essential process involves preparing DNA or RNA samples, ensuring the accuracy and quality of sequencing outcomes. The demand for NGS sample preparation is propelled by its ability to provide critical insights into genetic material and biological functions. Innovations in nanotechnology, such as nano-sized magnetic beads, nanofluidics, and microfluidics, are reshaping the landscape of sample preparation. These cutting-edge techniques optimize efficiency by enabling quicker and more precise processing, ultimately reducing costs and turnaround times. As a result, NGS sample preparation is becoming more accessible to a wider range of researchers and clinicians, fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the NGS Sample Preparation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

NGS Sample Preparation Market Segments Analysis

Global NGS Sample Preparation Market is segmented by Products & Services, Workflow, Sample Type, Method, Application, End User and Region. Based on Products & Services, the market is segmented into Workstations/Instruments, Reagents & Consumables, Services. Based on Workflow, the market is segmented into DNA Fragmentation & Library Preparation, Target Enrichment, Quality Control. Based on Sample Type, the market is segmented into DNA, RNA. Based on Method, the market is segmented into Manual Sample Preparation, Microfluidic Sample Preparation, Automated Liquid Handling-based Sample Preparation. Based on Application, the market is segmented into Disease Diagnostics (Cancer Diagnostics, Reproductive Health Diagnostics, Infectious Disease Diagnostics, Others), Drug Discovery, Agricultural & Animal Research, Others. Based on End User, the market is segmented into Hospitals & Clinics, Academic Institutes & Research Centers, Pharma & Biotech Companies, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the NGS Sample Preparation Market

The NGS sample preparation market is propelled by its essential function in a wide range of genomic research applications, including gene expression analysis, variant detection, biomarker discovery, and metagenomics. As advancements in genomics progress, there is an increasing necessity for efficient, high-throughput sample preparation techniques tailored for next-generation sequencing. This surge in demand underscores the importance of developing innovative methods that enhance the speed and reliability of sample processing, thereby supporting the broader goals of genomic research and enabling scientists to uncover critical insights into genetic material. The continuous evolution of these technologies further drives market growth and research capabilities.

Restraints in the NGS Sample Preparation Market

The NGS Sample Preparation market faces significant challenges due to the enormous data volumes generated by next-generation sequencing. This data influx demands sophisticated bioinformatics tools and extensive storage solutions, complicating the analysis and management of genomic datasets. A skilled workforce of bioinformaticians is essential for navigating these complexities, alongside the need for a robust infrastructure and secure storage systems. These requirements can create barriers that hinder the widespread adoption and efficient implementation of NGS sample preparation techniques, ultimately limiting their accessibility and effectiveness in various genomic research and clinical applications.

Market Trends of the NGS Sample Preparation Market

A notable trend shaping the global Next-Generation Sequencing (NGS) sample preparation market is the escalating shift towards automated and high-throughput solutions. This movement is propelled by the necessity for efficient, scalable approaches to manage the increasing volume of samples associated with NGS workflows. Automated sample preparation systems offer significant benefits, including reduced manual intervention, superior reproducibility, heightened accuracy, and increased sample throughput. By integrating advanced robotics and innovative liquid handling technologies, these systems streamline various critical processes, such as DNA/RNA extraction, library preparation, and target enrichment, ultimately enhancing productivity and reliability in genomic analyses.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index
• Pricing Analysis

Global NGS Sample Preparation Market Size by Products & Services & CAGR (2026-2033)

• Market Overview
• Workstations/Instruments
• Reagents & Consumables
• Services

Global NGS Sample Preparation Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• DNA Fragmentation & Library Preparation
• Target Enrichment
• Quality Control

Global NGS Sample Preparation Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• DNA
• RNA

Global NGS Sample Preparation Market Size by Method & CAGR (2026-2033)

• Market Overview
• Manual Sample Preparation
• Microfluidic Sample Preparation
• Automated Liquid Handling-based Sample Preparation

Global NGS Sample Preparation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Others
• Drug Discovery
• Agricultural & Animal Research
• Others

Global NGS Sample Preparation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Academic Institutes & Research Centers
• Pharma & Biotech Companies
• Others

Global NGS Sample Preparation Market Size & CAGR (2026-2033)

• North America (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • US
  • Canada
• Europe (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products & Services, Workflow, Sample Type, Method, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nanjing Novogene Bio Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation